Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oliceridine vs sufentanil combined with propofol for painless bronchoscopy
ChiCTR2600123221Phase 4Not yet recruiting
- Sponsor
- Enze Hospital
- Start
- Apr 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of oliceridine in bronchitis (2 arms), sponsored by Enze Hospital. Primary endpoints: Patient and doctor satisfaction ratings and Hemodynamic parameters (MAP, HR, SpO2) at six time points. Planned start Apr 2026; status: not yet recruiting.
02
Drugs
oliceridine
03
Conditions
bronchitis
Beyond the preview
Go deeper on ChiCTR2600123221.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2600123221.